NCT02195804View on ClinicalTrials.gov

Bioavailability Study of Ranitidine Hydrochloride (Maximum Strength ZANTAC 150®) Compared to Two Different 150 mg Ranitidine Hydrochloride Oral Disintegrating Tablet (ODT) in Fasting, Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2009

Conditions
Healthy
Interventions
DRUG

Ranitidine hydrochloride ODT

Ranitidine hydrochloride ODT#1 150 mg (Vanilla-Mint)

DRUG

Ranitidine hydrochloride ODT RM

Ranitidine hydrochloride ODT Reduced Mannitol (RM) 150 mg Vanilla-Mint (ODT#2)

DRUG

Ranitidine hydrochloride

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY